- Home
- CREV vs TTNP Comparison
CREV vs TTNP Comparison
Compare CREV & TTNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CREV
- TTNP
- Stock Information
- Founded
- CREV 2007
- TTNP 1991
- Country
- CREV Ireland
- TTNP United States
- Employees
- CREV N/A
- TTNP N/A
- Industry
- CREV
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CREV
- TTNP Health Care
- Exchange
- CREV Nasdaq
- TTNP Nasdaq
- Market Cap
- CREV 6.0M
- TTNP 5.4M
- IPO Year
- CREV N/A
- TTNP 1996
- Fundamental
- Price
- CREV $4.16
- TTNP $4.23
- Analyst Decision
- CREV
- TTNP
- Analyst Count
- CREV 0
- TTNP 0
- Target Price
- CREV N/A
- TTNP N/A
- AVG Volume (30 Days)
- CREV 57.1K
- TTNP 92.5K
- Earning Date
- CREV 05-14-2025
- TTNP 08-14-2025
- Dividend Yield
- CREV N/A
- TTNP N/A
- EPS Growth
- CREV N/A
- TTNP N/A
- EPS
- CREV N/A
- TTNP N/A
- Revenue
- CREV $39,261,077.00
- TTNP N/A
- Revenue This Year
- CREV $40.76
- TTNP N/A
- Revenue Next Year
- CREV $86.18
- TTNP N/A
- P/E Ratio
- CREV N/A
- TTNP N/A
- Revenue Growth
- CREV 41.52
- TTNP N/A
- 52 Week Low
- CREV $2.00
- TTNP $3.03
- 52 Week High
- CREV $12.75
- TTNP $6.43
- Technical
- Relative Strength Index (RSI)
- CREV 48.40
- TTNP 45.73
- Support Level
- CREV $3.72
- TTNP $3.58
- Resistance Level
- CREV $5.02
- TTNP $4.45
- Average True Range (ATR)
- CREV 0.38
- TTNP 0.37
- MACD
- CREV -0.04
- TTNP -0.08
- Stochastic Oscillator
- CREV 33.85
- TTNP 36.93
About CREV Carbon Revolution Public Limited
Carbon Revolution PLC is an Australian-based technology company manufacturing carbon fiber wheels. It is an OEM supplier and a world-wide manufacturer of lightweight technology carbon fibre wheels to the automotive industry. The Company supplies wheels to OEMs across the globe for luxury and high-performance vehicles and SUVs, and is developing wheels for electric vehicles under contract for its OEM customers. The company generates maximum revenue Internationally.
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.